Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Cancer Treatment and Research Communications|April 30, 2026
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)Samuel A Kareff, Harris Krause, Andrew Elliott, et al.
JCO Precision Oncology|January 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient CohortGeorge Nassief, Tolulope Adeyelu, Andrew Elliott, et al.
Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.
Gynecologic Oncology|October 4, 2024
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinomaTullia Rushton, Harris B Krause, Timothy Samec, et al.
Molecular Cancer Research : MCR|June 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate CancerSharon H Choi, Elizabeth Pan, Andrew Elliott, et al.
Scientific Reports|March 12, 2021
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomesAndrew Elliott, Michelle Saul, Jia Zeng, et al.
Head & Neck|November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory NeuroblastomaElisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2026
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancerJennifer A Marks, Kieran Sweeney, Andrew Elliott, et al.
Cancer Research|April 8, 2025
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung AdenocarcinomaUtsav Sen, Charles Coleman, Nishant Gandhi, et al.
Molecular Cancer Therapeutics|September 25, 2023
MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass SignalingNan Chen, Logan C Tyler, Anh T Le, et al.
Pageof 20